Quipt Home Medical Corp. (NASDAQ:QIPT – Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 1,050,000 shares, a growth of 19.3% from the November 30th total of 880,100 shares. Approximately 2.7% of the shares of the company are short sold. Based on an average trading volume of 167,800 shares, the short-interest ratio is presently 6.3 days.
Insider Buying and Selling at Quipt Home Medical
In related news, VP Patrick Dennis Gamble purchased 17,000 shares of Quipt Home Medical stock in a transaction on Thursday, December 26th. The stock was purchased at an average cost of $2.45 per share, with a total value of $41,650.00. Following the acquisition, the vice president now directly owns 40,057 shares in the company, valued at approximately $98,139.65. This trade represents a 73.73 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 4.20% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in QIPT. Bank of New York Mellon Corp raised its holdings in shares of Quipt Home Medical by 32.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 129,738 shares of the company’s stock worth $418,000 after buying an additional 32,073 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of Quipt Home Medical by 21.0% during the second quarter. Rhumbline Advisers now owns 49,276 shares of the company’s stock valued at $159,000 after acquiring an additional 8,541 shares during the period. Hsbc Holdings PLC boosted its stake in shares of Quipt Home Medical by 10.4% in the 2nd quarter. Hsbc Holdings PLC now owns 52,522 shares of the company’s stock valued at $165,000 after purchasing an additional 4,969 shares in the last quarter. ProShare Advisors LLC bought a new stake in shares of Quipt Home Medical in the 2nd quarter worth about $35,000. Finally, SG Americas Securities LLC acquired a new stake in shares of Quipt Home Medical during the 3rd quarter worth about $44,000. Institutional investors own 42.85% of the company’s stock.
Quipt Home Medical Stock Performance
Quipt Home Medical (NASDAQ:QIPT – Get Free Report) last announced its quarterly earnings data on Monday, December 16th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.08). Quipt Home Medical had a negative net margin of 1.95% and a negative return on equity of 4.51%. Equities analysts forecast that Quipt Home Medical will post -0.1 EPS for the current fiscal year.
Quipt Home Medical Company Profile
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Featured Articles
- Five stocks we like better than Quipt Home Medical
- 5 Top Rated Dividend Stocks to Consider
- 3 Stocks Helping to Bring AI to Healthcare
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- How to Calculate Stock Profit
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.